1) PI : 하권수 (Kwon-Soo Ha, Ph.D.)
- 주소 : 의학1호관 303호
- 전화 : 033) 250-8833
- E-mail : ksha@kangwon.ac.kr
2) 연구원
- 문찬희 (박사과정 연구원)
- 고태용 (석사과정 연구원)
- 정성훈 (석사과정 연구원)
- 윤지석 (석사과정 연구원)
- 조우리 (연구원)
- Regulation of AMPK and GAPDH by transglutaminase 2 plays a pivotal role in
microvascular leakage in diabetic retinas. Diabetes. IF 6.2 (2024)
- Transglutaminase 2 in diabetes mellitus: Unraveling its multifaceted role and
2 therapeutic implications for vascular complications. Theranostics. IF 12.4 (2024)
- Proinsulin C-peptide inhibits high glucose-induced migration and invasion of ovarian
cancer cells. Biomedicine & Pharmacotherapy. IF 7.5 (2024)
- Therapeutic effect of ultra-long-lasting human C-peptide delivery against
hyperglycemia-induced neovascularization in diabetic retinopathy.
Theranostics. IF 11.6 (2023)
- Simultaneous attenuation of hyperglycemic memory-induced retinal, pulmonary,
and glomerular dysfunctions by proinsulin C-peptide in diabetes. BMC Medicine. IF 11.8 (2023)
- Systemic C-peptide supplementation ameliorates retinal neurodegeneration by
inhibiting VEGF-induced pathological events in diabetes. FASEB Journal. IF 5.834 (2023)
- Dopamine ameliorates hyperglyceimc memory-induced microvascular dysfunction in
diabetic retinopathy. FASEB Journal. IF 5.834 (2022)
- Polymer-based delivery of peptide drugs to treat diabetes: Normalizing hyperglycemia
and preventing diabetic complications. Biochip Journal. IF 4.229 (2022)
- C-peptide attenuates hyperglycemia-induced pulmonary fibrosis by inhibiting
transglutaminase 2. Journal of Molecular Endocrinology. IF 4.869 (2022)
- Midazolam Ameliorates Hyperglycemia-Induced Glomerular Endothelial Dysfunction by
Inhibiting Transglutaminase 2 in Diabetes. International Journal of Molecular
Sciences. IF 6.208 (2022)